Margarita Angerosa Selected Research

teferrol

1/2015	Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
8/2012	Comparison of early gastrointestinal tract and liver toxicity of the originator iron polymaltose complex (IPC) and an IPC similar preparation in non-anemic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margarita Angerosa Research Topics

Disease

8	Inflammation (Inflammations) 01/2017 - 08/2009
7	Proteinuria 01/2017 - 01/2003
7	Body Weight (Weight, Body) 01/2017 - 10/2002
5	Iron Deficiencies 01/2017 - 01/2008
5	Fibrosis (Cirrhosis) 01/2011 - 10/2002
4	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2014 - 02/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 01/2014
2	Chronic Renal Insufficiency 01/2014 - 01/2009
2	Anemia 01/2014 - 06/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2011 - 05/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2011 - 01/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2011 - 08/2009
2	Necrosis 11/2010 - 07/2002
2	Hyperoxaluria (Oxaluria) 11/2005 - 10/2002
2	Atrophy 01/2003 - 10/2002
1	Colitis 01/2015
1	Heart Failure 01/2014
1	Carcinoma in Situ 01/2014
1	Hypersensitivity (Allergy) 01/2014
1	Uterine Hemorrhage (Uterine Bleeding) 01/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2010
1	Hemorrhage 01/2008
1	Hypertension (High Blood Pressure) 07/2006
1	Crystalluria 01/2003
1	Nephrolithiasis 01/2003
1	Fatty Liver 07/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2002
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2002

Drug/Important Bio-Agent (IBA)

11	IronIBA 01/2017 - 01/2008
6	CreatinineIBA 01/2017 - 01/2003
6	Dextrans (Dextran)FDA Link 01/2017 - 11/2010
5	Saccharated Ferric Oxide (Venofer)FDA Link 01/2017 - 01/2009
5	ferric carboxymaltoseIBA 01/2017 - 01/2011
3	EnzymesIBA 01/2017 - 07/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2010
3	LipidsIBA 08/2011 - 07/2002
3	Collagen Type III (Type III Collagen)IBA 07/2006 - 10/2002
2	AntioxidantsIBA 01/2017 - 08/2009
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2017 - 01/2011
2	Saline SolutionIBA 12/2015 - 02/2012
2	teferrolIBA 01/2015 - 08/2012
2	CarbohydratesIBA 01/2014 - 05/2010
2	CholesterolIBA 08/2011 - 07/2002
2	Triglycerides (Triacylglycerol)IBA 08/2011 - 07/2002
2	Atenolol (Tenormin)FDA LinkGeneric 08/2011 - 05/2010
2	Nebivolol FDA Link 08/2011 - 05/2010
2	Pioglitazone (Actos)FDA Link 01/2011 - 08/2009
2	ThiazolidinedionesIBA 01/2011 - 08/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2003 - 10/2002
2	OxalatesIBA 01/2003 - 10/2002
1	iron isomaltoside 1000IBA 01/2017
1	Malondialdehyde (Propanedial)IBA 01/2017
1	Iron CompoundsIBA 01/2017
1	HepcidinsIBA 01/2015
1	ferrous sulfate FDA Link 01/2015
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	Coloring Agents (Dyes)IBA 01/2014
1	nephrinIBA 08/2011
1	Insulin (Novolin)FDA Link 08/2011
1	NPHS2 proteinIBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 08/2011
1	Proteins (Proteins, Gene)FDA Link 08/2011
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	Connective Tissue Growth FactorIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2011
1	PPAR gammaIBA 08/2009
1	PPAR-gamma AgonistsIBA 08/2009
1	Biological ProductsIBA 01/2009
1	Transferrin (beta 2 Transferrin)IBA 01/2009
1	candesartanIBA 07/2006
1	Hydralazine (Apresoline)FDA LinkGeneric 07/2006
1	ChemokinesIBA 11/2005
1	NF-kappa B (NF-kB)IBA 11/2005
1	CytokinesIBA 11/2005
1	Calcium OxalateIBA 01/2003
1	Thiobarbituric Acid Reactive SubstancesIBA 10/2002
1	AngiotensinsIBA 10/2002
1	Monoclonal AntibodiesIBA 10/2002
1	Type 1 Angiotensin ReceptorIBA 10/2002
1	Losartan (Cozaar)FDA LinkGeneric 10/2002
1	Angiotensin IIIBA 10/2002
1	FatsIBA 07/2002
1	Enalapril FDA LinkGeneric 07/2002
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2002
1	Alanine Transaminase (SGPT)IBA 07/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2002

Therapy/Procedure

4	Therapeutics 01/2015 - 01/2008
1	Renal Dialysis (Hemodialysis) 01/2014
1	Glycemic Control 01/2011